Clinical trial
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following…
NCT00185757 · Robert Negrin, Other · Unknown status
Key facts
| NCT number | NCT00185757 |
|---|---|
| Title | Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation |
| Official title | Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation |
| Lead sponsor | Robert Negrin, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Blood and Marrow Transplant (BMT) |
| Intervention type | Drug |
| Interventions | Cytokine Induced Killer Cells |
| Enrollment | 20 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: